- Home
- CPS vs OVID Comparison
CPS vs OVID Comparison
Compare CPS & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPS | OVID |
|---|---|---|
| Founded | 1960 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 475.9M | 562.5M |
| IPO Year | 2005 | 2017 |
Fundamental Metrics
Financial Performance| Metric | CPS | OVID |
|---|---|---|
| Price | $21.83 | $2.46 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $43.00 | $5.92 |
| AVG Volume (30 Days) | 220.9K | ★ 1.3M |
| Earning Date | 10-29-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 94.87 | 3.90 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $7,252,000.00 |
| Revenue This Year | $3.82 | N/A |
| Revenue Next Year | $4.60 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1181.27 |
| 52 Week Low | $20.25 | $1.18 |
| 52 Week High | $47.98 | $3.11 |
Technical Indicators
Market Signals| Indicator | CPS | OVID |
|---|---|---|
| Relative Strength Index (RSI) | 30.97 | 39.28 |
| Support Level | N/A | $2.38 |
| Resistance Level | $31.24 | $2.79 |
| Average True Range (ATR) | 1.02 | 0.12 |
| MACD | -0.13 | -0.03 |
| Stochastic Oscillator | 14.81 | 18.59 |
Price Performance
Historical ComparisonAbout CPS Cooper-Standard Holdings Inc.
Cooper-Standard Holdings Inc is engaged in the manufacture of sealing and fluid handling systems (consisting of fuel and brake delivery systems and fluid transfer systems). Its products are designed for passenger vehicles and light trucks that are manufactured by automotive original equipment manufacturers (OEMs) and replacement markets. It has two reportable segments: Sealing Systems and Fluid Handling Systems. The group's geographic regions are North America, Europe, Asia Pacific, and South America.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.